The potential targets in immunotherapy of atherosclerosis. (4th May 2023)

• Record Type: Journal Article
• Authors: Aghamajidi, Azin; Gorgani, Melika; Shahba, Faezeh; Shafaghat, Zahra; Mojtabavi, Nazanin
• Is Part Of: International reviews of immunology. Volume 42:Number 3(2023)
• Page Start: 199
• Page End: 216
• Publication Date: 2023-05-04
• Subjects: Cardiovascular disease -- atherosclerosis -- immunotherapy -- targeted therapy; Immunology -- Periodicals; Autoimmune diseases -- Periodicals; 616.079
• DOI: 10.1080/08830185.2021.1988591
• Languages: English
• ISSNs: 0883-0185

Abstract

Abstract: Cardiovascular disease is the most common cause of death, which has the highest mortality rate worldwide. Although a diverse range of inflammatory diseases can affect the cardiovascular system, however, heart failure and stroke occur due to atherosclerosis. Atherosclerosis is a chronic autoinflammatory disease of small to large vessels in which different immune mediators are involved in lipid plaque formation and inflammatory vascular remodeling process. A better understanding of the pathophysiology of atherosclerosis may lead to uncovering immunomodulatory therapies. Despite present diagnostic and therapeutic methods, the lack of immunotherapy in the prevention and treatment of atherosclerosis is perceptible. In this review, we will discuss the promising immunological-based therapeutics and novel preventive approaches for atherosclerosis. This study could provide new insights into a better perception of targeted therapeutic pathways and biological therapies.